Study of Imaging and Molecular Biomarkers in Uncomplicated Rhegmatogenous Retinal Detachment

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity College, London

About this trial

Disease or general study area: Uncomplicated rhegmatogenous retinal detachment (RRD) and risk of proliferative vittroretinopathy (PVR)

Purpose and nature of the study:

1. Characterise the cytokine profile of vitreous fluid in uncomplicated RRD. 2. Develop a risk model to predict development of PVR after retinal detachment surgery using imaging and molecular biomarkers. 3. To develop deep learning/artificial intelligence (AI) models for PVR detection in retinal detachment.

Inclusion criteria:

50 adult ( ≥18 years) patients with uncomplicated rhegmatogenous retinal detachments without PVR.

What participating will involve:

Pre- and post-operative assessments and intervention will follow standard of care for patients with rhegmatogenous retinal detachments.

Additional intervention will include non-invasive imaging of anterior chamber flare, vitreous, wide-field retina, macula optical coherence tomography (OCT) and macula OCT-angiography (OCT-A) as well as, seeking participant's consent on collecting their vitreous fluid at time of their surgery for cytokine analysis.

Eligibility criteria

Qualifiers

Adults ≥18 years

Uncomplicated primary rhegmatogenous retinal detachment

PVD present

No PVR-A/B/C

Disqualifiers

Patients <18 years

Patients lacking capacity

Previous vitrectomy

Previous cryopexy

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Sponsors and collaborators